Plasma levels of the lymphangiogenic factors VEGF-C, VEGF-D, and CXCL-12 are elevated in advanced diabetic nephropathy
Objective Early biomarkers for diabetic nephropathy progression remain limited. This study aims to investigate whether plasma levels of VEGF-C, VEGF-D, and CXCL-12 can reflect the severity of diabetic kidney disease (DKD), and to evaluate their potential as biomarkers for disease monitoring.Methods...
Saved in:
| Main Authors: | Qingshan Tian, Fan Zhang, Zhichao Yang, Ji Miao, Hao Wu, Zhenzhong Zheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2536196 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression of endothelin in experimental myocardial infarction in a changed concentration of FGF and VEGF
by: M. G. Shurygin, et al.
Published: (2013-02-01) -
Microneedles with Interdigitated Electrodes for In Situ Impedimetric VEGF Sensing
by: Ritu Das, et al.
Published: (2025-05-01) -
The clinical significance of CXCL16 in the treatment of advanced non‐small cell lung cancer
by: Yuji Shibata, et al.
Published: (2020-05-01) -
The Effects of VEGF Signal Pathway on Etiopathogenesis and AntiVEGF Treatments in Childhood Cancers
by: Ali Kazdal, et al.
Published: (2023-09-01) -
Systemic Effects of Intravitreal Anti-VEGF Therapy: A Review of Safety across Organ Systems
by: Mousumi Banerjee, et al.
Published: (2025-06-01)